B cell maturation antigen (BCMA), a transmembrane glycoprotein belonging to tumor necrosis factor (TNF) receptor superfamily, is the most commonly used surface antigen target for multiple myeloma CAR-T. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.